NEW YORK (GenomeWeb News) — Qiagen and Exosome Diagnostics said today that they have expanded their collaboration to develop non-invasive in vitro molecular diagnostics.

The diagnostics will be based on Exosome's proprietary methods for purifying nucleic acids from biofluid exosomes and other microvesicles with Qiagen's sample prep technologies to create "cost-effective, easy-to-use, and automated sample-to-results workflows," the companies said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.